Premium
Grazax: sublingual immunotherapy for grass pollen allergy
Author(s) -
Chaplin Steve,
Durham Stephen
Publication year - 2008
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.269
Subject(s) - medicine , hay fever , sublingual immunotherapy , allergy , pollen , adverse effect , allergen immunotherapy , dermatology , immunology , allergen , pharmacology , botany , biology
Grazax is a novel sublingual formulation of grass pollen allergen for the treatment of hay fever in adults. In our Drugs in focus review Steve Chaplin presents the clinical data relating to its efficacy and adverse effects, and Professor Stephen Durham comments on its place in therapy. Copyright © 2008 Wiley Interface Ltd